Application of patient-derived organotypic tumor spheroids to guide combination immunotherapy for advanced HCC: a case report

Fu-Yi Wang, Li-Long Zhu, Cheng Ji, Jie Deng, Lu Han, Fei Song, Zhong Chen

Open source

DOI
10.3389/fonc.2026.1744326
Published
2026-06-02
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1744326,
  title = {Application of patient-derived organotypic tumor spheroids to guide combination immunotherapy for advanced HCC: a case report},
  author = {Fu-Yi Wang and Li-Long Zhu and Cheng Ji and Jie Deng and Lu Han and Fei Song and Zhong Chen},
  year = {2026},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2026.1744326},
  url = {https://doi.org/10.3389/fonc.2026.1744326}
}

RIS

TY  - JOUR
TI  - Application of patient-derived organotypic tumor spheroids to guide combination immunotherapy for advanced HCC: a case report
AU  - Fu-Yi Wang
AU  - Li-Long Zhu
AU  - Cheng Ji
AU  - Jie Deng
AU  - Lu Han
AU  - Fei Song
AU  - Zhong Chen
PY  - 2026
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1744326
UR  - https://doi.org/10.3389/fonc.2026.1744326
ER  - 

APA

Wang, F., Zhu, L., Ji, C., Deng, J., Han, L., Song, F., & Chen, Z. (2026). Application of patient-derived organotypic tumor spheroids to guide combination immunotherapy for advanced HCC: a case report. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1744326

Source records